Copyright Reports & Markets. All rights reserved.

Global Implantable Neurostimulation Devices Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Implantable Neurostimulation Devices Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Implantable Neurostimulation Devices Market Size Growth Rate by Product
      • 1.4.2 Spinal Cord Stimulation (SCS)
      • 1.4.3 Gastric Electric Stimulation (GES)
      • 1.4.4 Deep Brain Stimulation (DBS)
      • 1.4.5 Sacral Nerve Stimulation (SNS)
      • 1.4.6 Vagus Nerve Stimulation (VNS)
      • 1.4.7 Other
    • 1.5 Market by End User
      • 1.5.1 Global Implantable Neurostimulation Devices Market Size Growth Rate by End User
      • 1.5.2 Pain Management
      • 1.5.3 Parkinson's Disease
      • 1.5.4 Urinary and Fecal Incontinence
      • 1.5.5 Epilepsy
      • 1.5.6 Gastroparesis
      • 1.5.7 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Implantable Neurostimulation Devices Market Size
      • 2.1.1 Global Implantable Neurostimulation Devices Revenue 2014-2025
      • 2.1.2 Global Implantable Neurostimulation Devices Sales 2014-2025
    • 2.2 Implantable Neurostimulation Devices Growth Rate by Regions
      • 2.2.1 Global Implantable Neurostimulation Devices Sales by Regions
      • 2.2.2 Global Implantable Neurostimulation Devices Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Implantable Neurostimulation Devices Sales by Manufacturers
      • 3.1.1 Implantable Neurostimulation Devices Sales by Manufacturers
      • 3.1.2 Implantable Neurostimulation Devices Sales Market Share by Manufacturers
      • 3.1.3 Global Implantable Neurostimulation Devices Market Concentration Ratio (CR5 and HHI)
    • 3.2 Implantable Neurostimulation Devices Revenue by Manufacturers
      • 3.2.1 Implantable Neurostimulation Devices Revenue by Manufacturers (2014-2019)
      • 3.2.2 Implantable Neurostimulation Devices Revenue Share by Manufacturers (2014-2019)
    • 3.3 Implantable Neurostimulation Devices Price by Manufacturers
    • 3.4 Implantable Neurostimulation Devices Manufacturing Base Distribution, Product Types
      • 3.4.1 Implantable Neurostimulation Devices Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Implantable Neurostimulation Devices Product Type
      • 3.4.3 Date of International Manufacturers Enter into Implantable Neurostimulation Devices Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Implantable Neurostimulation Devices Sales by Product
    • 4.2 Global Implantable Neurostimulation Devices Revenue by Product
    • 4.3 Implantable Neurostimulation Devices Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Implantable Neurostimulation Devices Breakdown Data by End User

    6 North America

    • 6.1 North America Implantable Neurostimulation Devices by Countries
      • 6.1.1 North America Implantable Neurostimulation Devices Sales by Countries
      • 6.1.2 North America Implantable Neurostimulation Devices Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Implantable Neurostimulation Devices by Product
    • 6.3 North America Implantable Neurostimulation Devices by End User

    7 Europe

    • 7.1 Europe Implantable Neurostimulation Devices by Countries
      • 7.1.1 Europe Implantable Neurostimulation Devices Sales by Countries
      • 7.1.2 Europe Implantable Neurostimulation Devices Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Implantable Neurostimulation Devices by Product
    • 7.3 Europe Implantable Neurostimulation Devices by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Implantable Neurostimulation Devices by Countries
      • 8.1.1 Asia Pacific Implantable Neurostimulation Devices Sales by Countries
      • 8.1.2 Asia Pacific Implantable Neurostimulation Devices Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Implantable Neurostimulation Devices by Product
    • 8.3 Asia Pacific Implantable Neurostimulation Devices by End User

    9 Central & South America

    • 9.1 Central & South America Implantable Neurostimulation Devices by Countries
      • 9.1.1 Central & South America Implantable Neurostimulation Devices Sales by Countries
      • 9.1.2 Central & South America Implantable Neurostimulation Devices Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Implantable Neurostimulation Devices by Product
    • 9.3 Central & South America Implantable Neurostimulation Devices by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Implantable Neurostimulation Devices by Countries
      • 10.1.1 Middle East and Africa Implantable Neurostimulation Devices Sales by Countries
      • 10.1.2 Middle East and Africa Implantable Neurostimulation Devices Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Implantable Neurostimulation Devices by Product
    • 10.3 Middle East and Africa Implantable Neurostimulation Devices by End User

    11 Company Profiles

    • 11.1 Medtronic
      • 11.1.1 Medtronic Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Medtronic Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Medtronic Implantable Neurostimulation Devices Products Offered
      • 11.1.5 Medtronic Recent Development
    • 11.2 Boston Scientific
      • 11.2.1 Boston Scientific Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Boston Scientific Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Boston Scientific Implantable Neurostimulation Devices Products Offered
      • 11.2.5 Boston Scientific Recent Development
    • 11.3 St. Jude Medical (Abbott)
      • 11.3.1 St. Jude Medical (Abbott) Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 St. Jude Medical (Abbott) Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 St. Jude Medical (Abbott) Implantable Neurostimulation Devices Products Offered
      • 11.3.5 St. Jude Medical (Abbott) Recent Development
    • 11.4 LivaNova
      • 11.4.1 LivaNova Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 LivaNova Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 LivaNova Implantable Neurostimulation Devices Products Offered
      • 11.4.5 LivaNova Recent Development
    • 11.5 Nevro
      • 11.5.1 Nevro Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Nevro Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Nevro Implantable Neurostimulation Devices Products Offered
      • 11.5.5 Nevro Recent Development
    • 11.6 NeuroPace
      • 11.6.1 NeuroPace Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 NeuroPace Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 NeuroPace Implantable Neurostimulation Devices Products Offered
      • 11.6.5 NeuroPace Recent Development
    • 11.7 Beijing Pins
      • 11.7.1 Beijing Pins Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Beijing Pins Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Beijing Pins Implantable Neurostimulation Devices Products Offered
      • 11.7.5 Beijing Pins Recent Development
    • 11.8 Synapse Biomedical
      • 11.8.1 Synapse Biomedical Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Synapse Biomedical Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Synapse Biomedical Implantable Neurostimulation Devices Products Offered
      • 11.8.5 Synapse Biomedical Recent Development

    12 Future Forecast

    • 12.1 Implantable Neurostimulation Devices Market Forecast by Regions
      • 12.1.1 Global Implantable Neurostimulation Devices Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Implantable Neurostimulation Devices Revenue Forecast by Regions 2019-2025
    • 12.2 Implantable Neurostimulation Devices Market Forecast by Product
      • 12.2.1 Global Implantable Neurostimulation Devices Sales Forecast by Product 2019-2025
      • 12.2.2 Global Implantable Neurostimulation Devices Revenue Forecast by Product 2019-2025
    • 12.3 Implantable Neurostimulation Devices Market Forecast by End User
    • 12.4 North America Implantable Neurostimulation Devices Forecast
    • 12.5 Europe Implantable Neurostimulation Devices Forecast
    • 12.6 Asia Pacific Implantable Neurostimulation Devices Forecast
    • 12.7 Central & South America Implantable Neurostimulation Devices Forecast
    • 12.8 Middle East and Africa Implantable Neurostimulation Devices Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Implantable Neurostimulation Devices Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Neurostimulation is a therapeutic activation of part of the nervous system using microelectrodes. The electrodes are used to interface with excitable tissue in order to either restore sensation, such as a cochlear implant for hearing, or control anorgan, such as a heart pacemaker.
      Neurostimulation technology improves the life quality of those who are severely paralyzed or suffering from profound losses to various sense organs. It serves as the key part of neural prosthetics for hearing aids, artificial vision, artificial limbs, and brain-machine interfaces. In the case of neural stimulation, mostly an electrical stimulation is utilized and charge-balanced biphasic constant current waveforms of capacitive coupled charge injection approaches are adopted. Alternatively, the transcranial magnetic stimulation has been proposed as a non-invasive method in which a magnetic field causes neurostimulation.
      Neurostimulation devices are implantable devices that help in the therapeutic activation of the nervous systems. These devices deliver electrical stimulation to the brain and nervous systems for the treatment of various types of neurological disorders such as pain, epilepsy, Parkinson's disease, depression, obsessive-compulsive disorder, dystonia, and tremors. These devices target specific areas of the brain or spinal cord by blocking the pain messages before they reach the brain.
      North America region is the largest supplier of implantable neurostimulation devices, with a production market share nearly 82% in 2016. Europe is the second largest supplier of implantable neurostimulation devices, enjoying production market share nearly 12% in 2016.
      North America is the largest consumption place, with a consumption market share nearly 42% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 31%.
      Market competition is intense. Medtronic, Boston Scientific, St. Jude Medical (Abbott), etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
      The global Implantable Neurostimulation Devices market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Implantable Neurostimulation Devices market based on company, product type, end user and key regions.

      This report studies the global market size of Implantable Neurostimulation Devices in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Implantable Neurostimulation Devices in these regions.
      This research report categorizes the global Implantable Neurostimulation Devices market by top players/brands, region, type and end user. This report also studies the global Implantable Neurostimulation Devices market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Medtronic
      Boston Scientific
      St. Jude Medical (Abbott)
      LivaNova
      Nevro
      NeuroPace
      Beijing Pins
      Synapse Biomedical

      Market size by Product
      Spinal Cord Stimulation (SCS)
      Gastric Electric Stimulation (GES)
      Deep Brain Stimulation (DBS)
      Sacral Nerve Stimulation (SNS)
      Vagus Nerve Stimulation (VNS)
      Other
      Market size by End User
      Pain Management
      Parkinson's Disease
      Urinary and Fecal Incontinence
      Epilepsy
      Gastroparesis
      Other

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Implantable Neurostimulation Devices market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Implantable Neurostimulation Devices market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Implantable Neurostimulation Devices companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Implantable Neurostimulation Devices submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Implantable Neurostimulation Devices are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Implantable Neurostimulation Devices market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now